Skip to main content

FDA & Regulatory

Investigational New Drug Application

An Investigational New Drug (IND) application is the request a sponsor files with the FDA to begin human clinical trials. Clearance of the IND allows a candidate to move from preclinical work into Phase 1.

Category
FDA & Regulatory
Abbreviation
IND
BioSniper AIPage evidence connected

Prepared research question

How does Investigational New Drug Application affect the view of a biotech company in practice?

Run cited research

Traceable citations · Unknowns marked

An Investigational New Drug (IND) application is the request a sponsor files with the FDA to begin human clinical trials. Clearance of the IND allows a candidate to move from preclinical work into Phase 1.

Related terms

From term to thesis rule

Investigate how Investigational New Drug Application changes a biotech thesis

Define when Investigational New Drug Application should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.